These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 30266866)
1. The probacterial effect of type I interferon signaling requires its own negative regulator USP18. Shaabani N; Honke N; Nguyen N; Huang Z; Arimoto KI; Lazar D; Loe TK; Lang KS; Prinz M; Knobeloch KP; Zhang DE; Teijaro JR Sci Immunol; 2018 Sep; 3(27):. PubMed ID: 30266866 [TBL] [Abstract][Full Text] [Related]
2. IFN-β, but not IFN-α, is Responsible for the Pro-Bacterial Effect of Type I Interferon. Shaabani N; Vartabedian VF; Nguyen N; Honke N; Huang Z; Teijaro JR Cell Physiol Biochem; 2021 May; 55(3):256-264. PubMed ID: 33984198 [TBL] [Abstract][Full Text] [Related]
3. Lipopolysaccharide and Tumor Necrosis Factor Alpha Inhibit Interferon Signaling in Hepatocytes by Increasing Ubiquitin-Like Protease 18 (USP18) Expression. MacParland SA; Ma XZ; Chen L; Khattar R; Cherepanov V; Selzner M; Feld JJ; Selzner N; McGilvray ID J Virol; 2016 Jun; 90(12):5549-5560. PubMed ID: 27009955 [TBL] [Abstract][Full Text] [Related]
4. Differential Type I Interferon Signaling Is a Master Regulator of Susceptibility to Postinfluenza Bacterial Superinfection. Shepardson KM; Larson K; Morton RV; Prigge JR; Schmidt EE; Huber VC; Rynda-Apple A mBio; 2016 May; 7(3):. PubMed ID: 27143388 [TBL] [Abstract][Full Text] [Related]
5. Hypersensitivity to type I interferon as a cause of hydrocephalus development. Arimoto KI; Zhang Y; Matsuura S; Miyauchi S; Zhang DE Brain Res; 2024 Oct; 1840():149082. PubMed ID: 38866307 [TBL] [Abstract][Full Text] [Related]
7. USP18 is a significant driver of memory CD4 T-cell reduced viability caused by type I IFN signaling during primary HIV-1 infection. Dagenais-Lussier X; Loucif H; Cadorel H; Blumberger J; Isnard S; Bego MG; Cohen ÉA; Routy JP; van Grevenynghe J; PLoS Pathog; 2019 Oct; 15(10):e1008060. PubMed ID: 31658294 [TBL] [Abstract][Full Text] [Related]
8. Contribution of increased ISG15, ISGylation and deregulated type I IFN signaling in Usp18 mutant mice during the course of bacterial infections. Dauphinee SM; Richer E; Eva MM; McIntosh F; Paquet M; Dangoor D; Burkart C; Zhang DE; Gruenheid S; Gros P; Behr M; Malo D Genes Immun; 2014; 15(5):282-92. PubMed ID: 24807690 [TBL] [Abstract][Full Text] [Related]
9. USP18 enhances dengue virus replication by regulating mitochondrial DNA release. Lai JH; Wu DW; Wu CH; Hung LF; Huang CY; Ka SM; Chen A; Ho LJ Sci Rep; 2023 Nov; 13(1):20126. PubMed ID: 37978268 [TBL] [Abstract][Full Text] [Related]
10. Type I IFN Does Not Promote Susceptibility to Foodborne Listeria monocytogenes. Pitts MG; Myers-Morales T; D'Orazio SE J Immunol; 2016 Apr; 196(7):3109-16. PubMed ID: 26895837 [TBL] [Abstract][Full Text] [Related]
11. Mice lacking the type I interferon receptor are resistant to Listeria monocytogenes. Auerbuch V; Brockstedt DG; Meyer-Morse N; O'Riordan M; Portnoy DA J Exp Med; 2004 Aug; 200(4):527-33. PubMed ID: 15302899 [TBL] [Abstract][Full Text] [Related]
12. ITAM-coupled receptors inhibit IFNAR signaling and alter macrophage responses to TLR4 and Listeria monocytogenes. Huynh L; Wang L; Shi C; Park-Min KH; Ivashkiv LB J Immunol; 2012 Apr; 188(7):3447-57. PubMed ID: 22368279 [TBL] [Abstract][Full Text] [Related]
13. Type I IFN induction in response to Listeria monocytogenes in human macrophages: evidence for a differential activation of IFN regulatory factor 3 (IRF3). Reimer T; Schweizer M; Jungi TW J Immunol; 2007 Jul; 179(2):1166-77. PubMed ID: 17617610 [TBL] [Abstract][Full Text] [Related]
14. Gut microbial translocation corrupts myeloid cell function to control bacterial infection during liver cirrhosis. Hackstein CP; Assmus LM; Welz M; Klein S; Schwandt T; Schultze J; Förster I; Gondorf F; Beyer M; Kroy D; Kurts C; Trebicka J; Kastenmüller W; Knolle PA; Abdullah Z Gut; 2017 Mar; 66(3):507-518. PubMed ID: 27432540 [TBL] [Abstract][Full Text] [Related]
15. IFNAR2 Is Required for Anti-influenza Immunity and Alters Susceptibility to Post-influenza Bacterial Superinfections. Shepardson KM; Larson K; Johns LL; Stanek K; Cho H; Wellham J; Henderson H; Rynda-Apple A Front Immunol; 2018; 9():2589. PubMed ID: 30473701 [TBL] [Abstract][Full Text] [Related]
16. ATF3 provides protection from Staphylococcus aureus and Listeria monocytogenes infections. Nguyen CT; Luong TT; Lee S; Kim GL; Pyo S; Rhee DK FEMS Microbiol Lett; 2016 Apr; 363(8):. PubMed ID: 26989156 [TBL] [Abstract][Full Text] [Related]